Your session is about to expire
← Back to Search
Radiation Therapy
Brass Mesh Bolus for Breast Cancer
N/A
Recruiting
Research Sponsored by Nova Scotia Cancer Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1 year
Awards & highlights
No Placebo-Only Group
Summary
This trial tests if daily use of a brass mesh bolus can replace the current standard of care for chest wall radiation after mastectomy.
Who is the study for?
This trial is for women who have had a mastectomy to treat breast cancer and are undergoing rotational chest wall radiotherapy. It's specifically for those who would normally use Superflab bolus on some days of treatment, but not daily.
What is being tested?
The study is testing if using brass mesh bolus every day can give the same dose as the current standard (Superflab bolus) used every other day in post-mastectomy radiation therapy with rotational 6 MV photon delivery.
What are the potential side effects?
While specific side effects aren't listed, typical side effects from radiation therapy may include skin irritation or redness where the brass mesh bolus is applied, fatigue, and potential discomfort during application.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion, an average of 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1 year
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Skin Dose Enhancement Under Brass Mesh Bolus
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Post-Mastectomy Radiation Therapy PatientsExperimental Treatment1 Intervention
Any patient who is going through radiation to their chest wall following mastectomy using a rotational delivery technique and 6 MV, and uses Superflab bolus for some but not all fractions of radiotherapy
Find a Location
Who is running the clinical trial?
Michael KucharczykUNKNOWN
Hannah DahnUNKNOWN
Nova Scotia Cancer CentreLead Sponsor
4 Previous Clinical Trials
151 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- Patients who need frequent injections or have severe skin problems will not be included.
Research Study Groups:
This trial has the following groups:- Group 1: Post-Mastectomy Radiation Therapy Patients
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.